We are analyzing https://link.springer.com/article/10.1007/s11033-025-10398-2.

Title:
Effects of 5-azacytidine and N6-methyladenosine combination on apoptosis and stemness in human breast cancer stem cells | Molecular Biology Reports
Description:
Background This study investigates the combined effects of the epigenetic anticancer drug 5-azacytidine (5-Aza) and N6-methyladenosine (m6A) on breast cancer stem cells (CSCs) and normal breast epithelial cells. CSCs are characterized by their ability to self-renew, their resistance to conventional therapies, and their role in metastasis, presenting a significant challenge in breast cancer treatment. Methods and results The study utilized flow cytometry to isolate CD44 + /CD24low CSCs from MCF-7 breast cancer cells and evaluated these cells through spheroid formation assays. The results demonstrated that both 5-Aza and m6A, both individually and in combination, exert cytotoxic effects on CSCs, induce apoptosis, and reduce their migratory capacity. Importantly, these treatments did not produce similar effects on normal breast epithelial cells (MCF-10A), indicating selective action on CSCs. Gene expression analysis revealed that treatment with 5-Aza, m6A, and their combination altered the expression of key stem cell-related genes, including OCT4, NANOG, SOX2, and c-MYC, which are associated with CSC self-renewal and malignancy. Conclusions These findings suggest that epigenetic modulation through 5-Aza and m6A could effectively target CSCs, disrupting their ability to drive tumor progression and metastasis, particularly in aggressive breast cancer subtypes. This study highlights the potential of 5-Aza and m6A as a combinatorial therapeutic approach, offering a promising avenue for improving treatment outcomes in breast cancer patients, especially those with therapy-resistant disease. Further clinical investigation is needed to validate these findings and explore their therapeutic implications. Graphical abstract
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 8,170,536 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

cancer, article, pubmed, cells, stem, google, scholar, breast, cas, central, cell, nmethyladenosine, epigenetic, content, effects, azacytidine, caner, aza, cscs, privacy, cookies, data, biology, combination, stemness, ayse, study, metastasis, access, university, turkey, springer, analysis, information, publish, research, search, discover, methylation, biol, httpsdoiorgs, author, authors, department, ege, izmir, writing, editing, applicable, nature,

Topics {✒️}

month download article/chapter dna methylation insulinoma β-tc-6 cells cbx6-mediated transcriptional repression cancer stem cells cancer stem cells stem cell landscape stem cells access rna n6-methyladenosine modification isolate cd44 + /cd24low cscs breast cancer patients advanced breast cancer full article pdf breast cancer treatment stem cells 32 stem cells 12 spheroid formation assays privacy choices/manage cookies predicts cancer outcome sonic hedgehog signaling targeting epigenetic modifiers article mukhtarova main rna modifications cancer cells breast cancer epithelial-mesenchymal transition related subjects accepted manuscript version therapy-resistant disease promotes cytotoxic autophagy epigenetics exert cytotoxic effects holds exclusive rights ayse caner n6-methyladenosine combination medical biology european economic area indicating selective action produce similar effects modulating epigenetic modifications conditions privacy policy tumor immune microenvironment combination epigenetic therapy personal data cancer therapy combinatorial therapeutic approach cell cycle 12 article log effectively target cscs improving treatment outcomes

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Effects of 5-azacytidine and N6-methyladenosine combination on apoptosis and stemness in human breast cancer stem cells
         description:This study investigates the combined effects of the epigenetic anticancer drug 5-azacytidine (5-Aza) and N6-methyladenosine (m6A) on breast cancer stem cells (CSCs) and normal breast epithelial cells. CSCs are characterized by their ability to self-renew, their resistance to conventional therapies, and their role in metastasis, presenting a significant challenge in breast cancer treatment. The study utilized flow cytometry to isolate CD44 + /CD24low CSCs from MCF-7 breast cancer cells and evaluated these cells through spheroid formation assays. The results demonstrated that both 5-Aza and m6A, both individually and in combination, exert cytotoxic effects on CSCs, induce apoptosis, and reduce their migratory capacity. Importantly, these treatments did not produce similar effects on normal breast epithelial cells (MCF-10A), indicating selective action on CSCs. Gene expression analysis revealed that treatment with 5-Aza, m6A, and their combination altered the expression of key stem cell-related genes, including OCT4, NANOG, SOX2, and c-MYC, which are associated with CSC self-renewal and malignancy. These findings suggest that epigenetic modulation through 5-Aza and m6A could effectively target CSCs, disrupting their ability to drive tumor progression and metastasis, particularly in aggressive breast cancer subtypes. This study highlights the potential of 5-Aza and m6A as a combinatorial therapeutic approach, offering a promising avenue for improving treatment outcomes in breast cancer patients, especially those with therapy-resistant disease. Further clinical investigation is needed to validate these findings and explore their therapeutic implications.
         datePublished:2025-03-07T00:00:00Z
         dateModified:2025-03-07T00:00:00Z
         pageStart:1
         pageEnd:11
         sameAs:https://doi.org/10.1007/s11033-025-10398-2
         keywords:
            Breast cancer
            Cancer stem cells
            5-azacytidine (5-Aza)
            N6-methyladenosine (m6A)
            Stemness
            Animal Biochemistry
            Animal Anatomy / Morphology / Histology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-025-10398-2/MediaObjects/11033_2025_10398_Figa_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-025-10398-2/MediaObjects/11033_2025_10398_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-025-10398-2/MediaObjects/11033_2025_10398_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-025-10398-2/MediaObjects/11033_2025_10398_Fig3_HTML.png
         isPartOf:
            name:Molecular Biology Reports
            issn:
               1573-4978
               0301-4851
            volumeNumber:52
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Gunel Mukhtarova
               affiliation:
                     name:Institute of Health Sciences, Ege University
                     address:
                        name:Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mesude Angin
               affiliation:
                     name:Balıkesir University
                     address:
                        name:Faculty of Medicine, Department of Medical Biology, Balıkesir University, Balıkesir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ayse Caner
               url:http://orcid.org/0000-0003-3058-9971
               affiliation:
                     name:Institute of Health Sciences, Ege University
                     address:
                        name:Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
                     name:Ege University
                     address:
                        name:Translational Pulmonary Research Center (EGESAM), Ege University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
                     name: Ege University
                     address:
                        name:Faculty of Medicine, Department of Medical Parasitology, Ege University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Cumhur Gunduz
               affiliation:
                     name: Ege University
                     address:
                        name:Faculty of Medicine, Department of Medical Biology, Ege University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Effects of 5-azacytidine and N6-methyladenosine combination on apoptosis and stemness in human breast cancer stem cells
      description:This study investigates the combined effects of the epigenetic anticancer drug 5-azacytidine (5-Aza) and N6-methyladenosine (m6A) on breast cancer stem cells (CSCs) and normal breast epithelial cells. CSCs are characterized by their ability to self-renew, their resistance to conventional therapies, and their role in metastasis, presenting a significant challenge in breast cancer treatment. The study utilized flow cytometry to isolate CD44 + /CD24low CSCs from MCF-7 breast cancer cells and evaluated these cells through spheroid formation assays. The results demonstrated that both 5-Aza and m6A, both individually and in combination, exert cytotoxic effects on CSCs, induce apoptosis, and reduce their migratory capacity. Importantly, these treatments did not produce similar effects on normal breast epithelial cells (MCF-10A), indicating selective action on CSCs. Gene expression analysis revealed that treatment with 5-Aza, m6A, and their combination altered the expression of key stem cell-related genes, including OCT4, NANOG, SOX2, and c-MYC, which are associated with CSC self-renewal and malignancy. These findings suggest that epigenetic modulation through 5-Aza and m6A could effectively target CSCs, disrupting their ability to drive tumor progression and metastasis, particularly in aggressive breast cancer subtypes. This study highlights the potential of 5-Aza and m6A as a combinatorial therapeutic approach, offering a promising avenue for improving treatment outcomes in breast cancer patients, especially those with therapy-resistant disease. Further clinical investigation is needed to validate these findings and explore their therapeutic implications.
      datePublished:2025-03-07T00:00:00Z
      dateModified:2025-03-07T00:00:00Z
      pageStart:1
      pageEnd:11
      sameAs:https://doi.org/10.1007/s11033-025-10398-2
      keywords:
         Breast cancer
         Cancer stem cells
         5-azacytidine (5-Aza)
         N6-methyladenosine (m6A)
         Stemness
         Animal Biochemistry
         Animal Anatomy / Morphology / Histology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-025-10398-2/MediaObjects/11033_2025_10398_Figa_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-025-10398-2/MediaObjects/11033_2025_10398_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-025-10398-2/MediaObjects/11033_2025_10398_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-025-10398-2/MediaObjects/11033_2025_10398_Fig3_HTML.png
      isPartOf:
         name:Molecular Biology Reports
         issn:
            1573-4978
            0301-4851
         volumeNumber:52
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Gunel Mukhtarova
            affiliation:
                  name:Institute of Health Sciences, Ege University
                  address:
                     name:Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mesude Angin
            affiliation:
                  name:Balıkesir University
                  address:
                     name:Faculty of Medicine, Department of Medical Biology, Balıkesir University, Balıkesir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ayse Caner
            url:http://orcid.org/0000-0003-3058-9971
            affiliation:
                  name:Institute of Health Sciences, Ege University
                  address:
                     name:Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
                  name:Ege University
                  address:
                     name:Translational Pulmonary Research Center (EGESAM), Ege University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
                  name: Ege University
                  address:
                     name:Faculty of Medicine, Department of Medical Parasitology, Ege University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Cumhur Gunduz
            affiliation:
                  name: Ege University
                  address:
                     name:Faculty of Medicine, Department of Medical Biology, Ege University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular Biology Reports
      issn:
         1573-4978
         0301-4851
      volumeNumber:52
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Institute of Health Sciences, Ege University
      address:
         name:Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey
         type:PostalAddress
      name:Balıkesir University
      address:
         name:Faculty of Medicine, Department of Medical Biology, Balıkesir University, Balıkesir, Turkey
         type:PostalAddress
      name:Institute of Health Sciences, Ege University
      address:
         name:Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey
         type:PostalAddress
      name:Ege University
      address:
         name:Translational Pulmonary Research Center (EGESAM), Ege University, Izmir, Turkey
         type:PostalAddress
      name: Ege University
      address:
         name:Faculty of Medicine, Department of Medical Parasitology, Ege University, Izmir, Turkey
         type:PostalAddress
      name: Ege University
      address:
         name:Faculty of Medicine, Department of Medical Biology, Ege University, Izmir, Turkey
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Gunel Mukhtarova
      affiliation:
            name:Institute of Health Sciences, Ege University
            address:
               name:Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Mesude Angin
      affiliation:
            name:Balıkesir University
            address:
               name:Faculty of Medicine, Department of Medical Biology, Balıkesir University, Balıkesir, Turkey
               type:PostalAddress
            type:Organization
      name:Ayse Caner
      url:http://orcid.org/0000-0003-3058-9971
      affiliation:
            name:Institute of Health Sciences, Ege University
            address:
               name:Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey
               type:PostalAddress
            type:Organization
            name:Ege University
            address:
               name:Translational Pulmonary Research Center (EGESAM), Ege University, Izmir, Turkey
               type:PostalAddress
            type:Organization
            name: Ege University
            address:
               name:Faculty of Medicine, Department of Medical Parasitology, Ege University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Cumhur Gunduz
      affiliation:
            name: Ege University
            address:
               name:Faculty of Medicine, Department of Medical Biology, Ege University, Izmir, Turkey
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey
      name:Faculty of Medicine, Department of Medical Biology, Balıkesir University, Balıkesir, Turkey
      name:Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey
      name:Translational Pulmonary Research Center (EGESAM), Ege University, Izmir, Turkey
      name:Faculty of Medicine, Department of Medical Parasitology, Ege University, Izmir, Turkey
      name:Faculty of Medicine, Department of Medical Biology, Ege University, Izmir, Turkey
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(132)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.47s.

LINK . SPRINGER . COM {}